Format

Send to

Choose Destination
J Med Virol. 2020 Mar 20. doi: 10.1002/jmv.25780. [Epub ahead of print]

Will COVID-19 be a litmus test for post-Ebola Sub-Saharan Africa?

Author information

1
Center for Medicines Use and Safety, Monash Institute for Pharmaceutical Sciences, Monash University, Melbourne, Australia.
2
Department of Population, Family and Reproductive Health, School of Public Health, University of Ghana, Accra, Ghana.
3
Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
4
Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.

Abstract

In 2014, the worst outbreak of Ebola virus disease (EVD) emerged in sub-Saharan Africa (SSA) causing fear and panic. The outbreak which started in Guinea quickly moved across to Sierra Leone and Liberia. With an average EVD case fatality rate of around 50% (range 25-90%), there were many casualties, and the number of recorded deaths exceeded 11,300 by June 2016.1 This article is protected by copyright. All rights reserved.

KEYWORDS:

Coronavirus; Disease control; Ebolavirus; Virus classification; Virus classificationVirus classificationVirus classification

PMID:
32196700
DOI:
10.1002/jmv.25780

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center